GlassScriptPhysician profile
Thomas K Jamieson
NPI 1538220561
$2,152.39
in general payments reported to CMS, 2019-2025
42 companies · $658 in 2025
The $658 reported for 2025 was more than what 86% of Sports Medicine (Family Medicine) providers received nationally (typical 2025 total: $113).
See the full distribution for Sports Medicine (Family Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $97.12 · 2022: $534 · 2023: $304 · 2024: $560 · 2025: $658.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,522.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,521.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $218.05 | 2019-2025 | |
| Novo Nordisk INC | $211.15 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Otsuka America Pharmaceutical, INC. | $204.45 | 2023-2025 | Rexulti |
| Abbvie INC. | $114.44 | 2022-2025 | |
| Vanda Pharmaceuticals INC. | $112.54 | 2022-2025 | Fanapt |
| Axsome Therapeutics, INC. | $110.21 | 2024-2025 | Auvelity |
| Viiv Healthcare Company | $92.38 | 2025 | Rukobia, Cabenuva, Apretude |
| Merck Sharp & Dohme LLC | $91.01 | 2024-2025 | Gardasil 9, Capvaxive, Gardasil |
| Lilly USA, LLC | $74.87 | 2022-2024 | Mounjaro, Zepbound |
| Antares Pharma, INC. | $72.02 | 2024-2025 | Xyosted |
| Amgen INC. | $68.24 | 2022-2024 | Repatha, Otezla |
| Grifols USA, LLC | $60.08 | 2023-2024 | Prolastin-C Liquid |
| Radius Health, INC. | $58.25 | 2023-2025 | Tymlos |
| Seqirus USA INC | $51.47 | 2023-2025 | Flucelvax Quadrivalent, Fluad Quadrivalent, Flucelvax |
| Bayer Healthcare Pharmaceuticals INC. | $43.97 | 2022-2025 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Jamieson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.